These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10605161)

  • 1. [High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?].
    Lopez M
    Clin Ter; 1999; 150(4):259-62. PubMed ID: 10605161
    [No Abstract]   [Full Text] [Related]  

  • 2. Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.
    Antman KH
    J Clin Oncol; 1999 Nov; 17(11 Suppl):30-4. PubMed ID: 10630259
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose chemotherapy for primary breast cancer: facts versus anecdotes.
    Hortobagyi GN
    J Clin Oncol; 1999 Nov; 17(11 Suppl):25-9. PubMed ID: 10630258
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-dose chemotherapy for metastatic breast cancer].
    Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
    Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dose density and dose intensity in the treatment of breast cancer].
    Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP
    Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research).
    Antman K
    Trans Am Clin Climatol Assoc; 2002; 113():56-66; discussion 66-7. PubMed ID: 12053718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dense chemotherapy for breast cancer: the story so far.
    Hudis C
    Br J Cancer; 2000 Jun; 82(12):1897-9. PubMed ID: 10864194
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy in breast cancer -- the perils of history uncontrolled.
    Miller KD; Sledge GW
    Medscape Womens Health; 2000; 5(3):E1. PubMed ID: 11109042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.
    Bruzzi P; Del Mastro L; Sormani MP; Bastholt L; Danova M; Focan C; Fountzilas G; Paul J; Rosso R; Venturini M
    J Clin Oncol; 2005 Aug; 23(22):5117-25. PubMed ID: 15955906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of dose-dense chemotherapy for breast cancer.
    Seidman AD
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose adjuvant chemotherapy for breast cancer: state of the art.
    Cottu PH; Cuvier C; Espié M
    Forum (Genova); 2002; 12(1):36-40. PubMed ID: 12634909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer.
    Rodenhuis S; Huitema AD; van Dam FS; de Vries EG; Beijnen JH
    Cancer J; 2000 Apr; 6 Suppl 2():S125-30. PubMed ID: 10803826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
    Livingston R; Crowley J
    J Clin Oncol; 1999 Nov; 17(11 Suppl):22-4. PubMed ID: 10630257
    [No Abstract]   [Full Text] [Related]  

  • 15. End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma RS
    J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
    Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
    J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemo in question. Higher doses may not help breast cancer--yet.
    Underwood A
    Newsweek; 1999 Apr; 133(17):64. PubMed ID: 10351750
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized clinical trials, clinical use, and hope: what relationship?
    Rettig RA; Jacobson PD; Farquhar CM; Aubry WM
    J Clin Oncol; 2008 May; 26(13):2223-4. PubMed ID: 18445852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.